Literature DB >> 25866194

Anti-neural antibody response in patients with post-treatment Lyme disease symptoms versus those with myalgic encephalomyelitis/chronic fatigue syndrome.

Mary Ajamian1, Michael Cooperstock2, Gary P Wormser3, Suzanne D Vernon4, Armin Alaedini5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25866194      PMCID: PMC4638178          DOI: 10.1016/j.bbi.2015.04.006

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


× No keyword cloud information.
  5 in total

Review 1.  Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works.

Authors:  B M Carruthers
Journal:  J Clin Pathol       Date:  2006-08-25       Impact factor: 3.411

2.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

3.  Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.

Authors:  Abhishek Chandra; Gary P Wormser; Mark S Klempner; Richard P Trevino; Mary K Crow; Norman Latov; Armin Alaedini
Journal:  Brain Behav Immun       Date:  2010-03-18       Impact factor: 7.217

4.  Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences.

Authors:  E A Gaudino; P K Coyle; L B Krupp
Journal:  Arch Neurol       Date:  1997-11

5.  No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank.

Authors:  David M Irlbeck; Suzanne D Vernon; K Kimberly McCleary; Lucinda Bateman; Nancy G Klimas; Charles W Lapp; Daniel L Peterson; James R Brown; Katja S Remlinger; David A Wilfret; Peter Gerondelis
Journal:  BMC Res Notes       Date:  2014-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.